Phase 1 Study of Zoledronic Acid in Sickle Cell Disease
Status:
Withdrawn
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The long-term goal of this study is to learn if Zoledronic Acid can prevent or reduce pain in
sickle cell disease. The goal of this study is to learn about the safety of Zoledronic Acid
in persons with sickle cell disease who experience chronic pain requiring medical treatment
or use of narcotics.